Risk of adverse events associated with upper and lower endoscopic ultrasound: a population-based cohort study

Background and study aim Endoscopic ultrasound (EUS) enables diagnostic evaluation and therapeutic interventions but is associated with adverse events. We conducted a population-based cohort study to determine the risk of adverse events for upper and lower EUS with and without fine-needle aspiration...

Full description

Bibliographic Details
Main Authors: Roshan Razik, Paul D. James, Rishad Khan, Courtney Maxwell, Yibing Ruan, Nauzer Forbes, Anita Williams, Divine Tanyingoh, Darren R. Brenner, Gilaad G. Kaplan, Robert J. Hilsden, Steven J. Heitman
Format: Article
Language:English
Published: Georg Thieme Verlag KG 2021-08-01
Series:Endoscopy International Open
Online Access:http://www.thieme-connect.de/DOI/DOI?10.1055/a-1512-9341
id doaj-04812f833da043bdae4336940f171bbc
record_format Article
spelling doaj-04812f833da043bdae4336940f171bbc2021-08-23T23:07:17ZengGeorg Thieme Verlag KGEndoscopy International Open2364-37222196-97362021-08-010909E1427E143410.1055/a-1512-9341Risk of adverse events associated with upper and lower endoscopic ultrasound: a population-based cohort studyRoshan Razik0Paul D. James1Rishad Khan2Courtney Maxwell3Yibing Ruan4Nauzer Forbes5Anita Williams6Divine Tanyingoh7Darren R. Brenner8Gilaad G. Kaplan9Robert J. Hilsden10Steven J. Heitman11Cleveland Clinic Akron General, Akron, Ohio, United StatesDepartment of Medicine, University Health Network, University of Toronto, Faculty of Medicine, Toronto, Ontario, CanadaDepartment of Medicine, University Health Network, University of Toronto, Faculty of Medicine, Toronto, Ontario, CanadaDepartment of Medicine, University of Calgary, Cumming School of Medicine, Calgary, Alberta, CanadaDepartment of Cancer Epidemiology and Prevention Research, Cancer Care Alberta, Alberta Health Services, Calgary, Alberta, CanadaDepartment of Medicine, University of Calgary, Cumming School of Medicine, Calgary, Alberta, CanadaAnalytics, Data Integration, Measurement and Reporting, Alberta Health Services, Calgary, Alberta, CanadaDepartment of Medicine, University of Calgary, Cumming School of Medicine, Calgary, Alberta, CanadaDepartment of Cancer Epidemiology and Prevention Research, Cancer Care Alberta, Alberta Health Services, Calgary, Alberta, CanadaDepartment of Medicine, University of Calgary, Cumming School of Medicine, Calgary, Alberta, CanadaDepartment of Medicine, University of Calgary, Cumming School of Medicine, Calgary, Alberta, CanadaDepartment of Medicine, University of Calgary, Cumming School of Medicine, Calgary, Alberta, CanadaBackground and study aim Endoscopic ultrasound (EUS) enables diagnostic evaluation and therapeutic interventions but is associated with adverse events. We conducted a population-based cohort study to determine the risk of adverse events for upper and lower EUS with and without fine-needle aspiration (FNA). Patients and methods All adults who underwent EUS and resided in Calgary in 2007–2013 were included. Endoscopy and provincial databases were used to identify EUS procedures, unplanned emergency department visits, and hospital admissions within 30 days of the procedures, which were then characterized through formal chart review. Adverse events were defined a priori and classified as definitely, possibly, or not related to EUS. The primary outcome was 30-day risk of adverse events classified as definitely or possibly related to EUS. Univariable and multivariable analyses were conducted with risk factors known to be associated with EUS adverse events. Results 2895 patients underwent 3552 EUS procedures: 3034 (85 %) upper EUS, of which 710 (23 %) included FNA, and 518 (15 %) lower EUS, of which 23 (4 %) involved FNA. Overall, 69 procedures (2 %) involved an adverse event that was either definitely or possibly related to EUS, with 33 (1 %) requiring hospitalization. None of the adverse events required intensive care or resulted in death. On multivariable analysis, only FNA was associated with increased risk of adverse events (odds ratio 6.43, 95 % confidence interval 3.92–10.55; P < 0.001). Conclusion Upper and lower EUS were generally safe but FNA substantially increased the risk of adverse events. EUS-related complications requiring hospitalization were rare.http://www.thieme-connect.de/DOI/DOI?10.1055/a-1512-9341
collection DOAJ
language English
format Article
sources DOAJ
author Roshan Razik
Paul D. James
Rishad Khan
Courtney Maxwell
Yibing Ruan
Nauzer Forbes
Anita Williams
Divine Tanyingoh
Darren R. Brenner
Gilaad G. Kaplan
Robert J. Hilsden
Steven J. Heitman
spellingShingle Roshan Razik
Paul D. James
Rishad Khan
Courtney Maxwell
Yibing Ruan
Nauzer Forbes
Anita Williams
Divine Tanyingoh
Darren R. Brenner
Gilaad G. Kaplan
Robert J. Hilsden
Steven J. Heitman
Risk of adverse events associated with upper and lower endoscopic ultrasound: a population-based cohort study
Endoscopy International Open
author_facet Roshan Razik
Paul D. James
Rishad Khan
Courtney Maxwell
Yibing Ruan
Nauzer Forbes
Anita Williams
Divine Tanyingoh
Darren R. Brenner
Gilaad G. Kaplan
Robert J. Hilsden
Steven J. Heitman
author_sort Roshan Razik
title Risk of adverse events associated with upper and lower endoscopic ultrasound: a population-based cohort study
title_short Risk of adverse events associated with upper and lower endoscopic ultrasound: a population-based cohort study
title_full Risk of adverse events associated with upper and lower endoscopic ultrasound: a population-based cohort study
title_fullStr Risk of adverse events associated with upper and lower endoscopic ultrasound: a population-based cohort study
title_full_unstemmed Risk of adverse events associated with upper and lower endoscopic ultrasound: a population-based cohort study
title_sort risk of adverse events associated with upper and lower endoscopic ultrasound: a population-based cohort study
publisher Georg Thieme Verlag KG
series Endoscopy International Open
issn 2364-3722
2196-9736
publishDate 2021-08-01
description Background and study aim Endoscopic ultrasound (EUS) enables diagnostic evaluation and therapeutic interventions but is associated with adverse events. We conducted a population-based cohort study to determine the risk of adverse events for upper and lower EUS with and without fine-needle aspiration (FNA). Patients and methods All adults who underwent EUS and resided in Calgary in 2007–2013 were included. Endoscopy and provincial databases were used to identify EUS procedures, unplanned emergency department visits, and hospital admissions within 30 days of the procedures, which were then characterized through formal chart review. Adverse events were defined a priori and classified as definitely, possibly, or not related to EUS. The primary outcome was 30-day risk of adverse events classified as definitely or possibly related to EUS. Univariable and multivariable analyses were conducted with risk factors known to be associated with EUS adverse events. Results 2895 patients underwent 3552 EUS procedures: 3034 (85 %) upper EUS, of which 710 (23 %) included FNA, and 518 (15 %) lower EUS, of which 23 (4 %) involved FNA. Overall, 69 procedures (2 %) involved an adverse event that was either definitely or possibly related to EUS, with 33 (1 %) requiring hospitalization. None of the adverse events required intensive care or resulted in death. On multivariable analysis, only FNA was associated with increased risk of adverse events (odds ratio 6.43, 95 % confidence interval 3.92–10.55; P < 0.001). Conclusion Upper and lower EUS were generally safe but FNA substantially increased the risk of adverse events. EUS-related complications requiring hospitalization were rare.
url http://www.thieme-connect.de/DOI/DOI?10.1055/a-1512-9341
work_keys_str_mv AT roshanrazik riskofadverseeventsassociatedwithupperandlowerendoscopicultrasoundapopulationbasedcohortstudy
AT pauldjames riskofadverseeventsassociatedwithupperandlowerendoscopicultrasoundapopulationbasedcohortstudy
AT rishadkhan riskofadverseeventsassociatedwithupperandlowerendoscopicultrasoundapopulationbasedcohortstudy
AT courtneymaxwell riskofadverseeventsassociatedwithupperandlowerendoscopicultrasoundapopulationbasedcohortstudy
AT yibingruan riskofadverseeventsassociatedwithupperandlowerendoscopicultrasoundapopulationbasedcohortstudy
AT nauzerforbes riskofadverseeventsassociatedwithupperandlowerendoscopicultrasoundapopulationbasedcohortstudy
AT anitawilliams riskofadverseeventsassociatedwithupperandlowerendoscopicultrasoundapopulationbasedcohortstudy
AT divinetanyingoh riskofadverseeventsassociatedwithupperandlowerendoscopicultrasoundapopulationbasedcohortstudy
AT darrenrbrenner riskofadverseeventsassociatedwithupperandlowerendoscopicultrasoundapopulationbasedcohortstudy
AT gilaadgkaplan riskofadverseeventsassociatedwithupperandlowerendoscopicultrasoundapopulationbasedcohortstudy
AT robertjhilsden riskofadverseeventsassociatedwithupperandlowerendoscopicultrasoundapopulationbasedcohortstudy
AT stevenjheitman riskofadverseeventsassociatedwithupperandlowerendoscopicultrasoundapopulationbasedcohortstudy
_version_ 1721198006117597184